Risk Factors of Death in the Decision to Install Artificial Intelligence Systems in the Management of Diabetes
Abstract
Diabetes represents a significant public health concern, affecting millions of individuals worldwide. Its prevalence is increasing, driven in part by lifestyle factors and the aging of the global population. This systematic review explores the potential of artificial intelligence (AI) in enhancing diabetes prevention, diagnosis, and management. The review highlights the promise of personalized and proactive healthcare enabled through AI. The research methodology employed an exhaustive review of the literature, the formulation of specific inclusion and exclusion criteria, a data extraction process from selected studies that focused on the role of AI in diabetes, and a comprehensive analysis to identify the specific domains and functions in which AI makes a significant contribution. The results of the conducted literature review indicate that artificial intelligence (AI) can be regarded as a transformative force in the following eight key areas within the field of diabetes care: 1) Management and Care of Diabetes, 2) Diagnostic and Imaging Technologies, 3) Health Monitoring Systems, 4) Development of Predictive Models, 5) Public Health Interventions, 6) Lifestyle and Dietary Management, 7) Enhancement of Clinical Decision Making, and 8) Engagement and Self-Management of Patients. Additionally, the utilization of AI may result in a reduction in the risk of mortality from diabetes.
Downloads
References
A. E. Gosmanov, A. R., Gosmanova, E. O., & Kitabchi, “Hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state.,” Endotext [Internet]., 2021.
D. J. Magliano, J. W. Sacre, J. L. Harding, E. W. Gregg, P. Z. Zimmet, and J. E. Shaw, “Young-onset type 2 diabetes mellitus — implications for morbidity and mortality,” Nat. Rev. Endocrinol., vol. 16, no. 6, pp. 321–331, Jun. 2020, doi: 10.1038/s41574-020-0334-z.
K. I. Galaviz, K. M. V. Narayan, F. Lobelo, and M. B. Weber, “Lifestyle and the Prevention of Type 2 Diabetes: A Status Report,” Am. J. Lifestyle Med., vol. 12, no. 1, pp. 4–20, Jan. 2018, doi: 10.1177/1559827615619159.
A. Daly and R. Hovorka, “Technology in the management of type 2 diabetes: Present status and future prospects,” Diabetes, Obes. Metab., vol. 23, no. 8, pp. 1722–1732, Aug. 2021, doi: 10.1111/dom.14418.
Z. Guan et al., “Artificial intelligence in diabetes management: Advancements, opportunities, and challenges,” Cell Reports Med., vol. 4, no. 10, p. 101213, Oct. 2023, doi: 10.1016/j.xcrm.2023.101213.
J. Huang et al., “Artificial Intelligence for Predicting and Diagnosing Complications of Diabetes,” J. Diabetes Sci. Technol., vol. 17, no. 1, pp. 224–238, Jan. 2023, doi: 10.1177/19322968221124583.
O. Ali, W. Abdelbaki, A. Shrestha, E. Elbasi, M. A. A. Alryalat, and Y. K. Dwivedi, “A systematic literature review of artificial intelligence in the healthcare sector: Benefits, challenges, methodologies, and functionalities,” J. Innov. Knowl., vol. 8, no. 1, p. 100333, Jan. 2023, doi: 10.1016/j.jik.2023.100333.
M. Avanzo et al., “Artificial intelligence applications in medical imaging: A review of the medical physics research in Italy,” Phys. Medica, vol. 83, pp. 221–241, Mar. 2021, doi: 10.1016/j.ejmp.2021.04.010.
M. Vettoretti, G. Cappon, A. Facchinetti, and G. Sparacino, “Advanced Diabetes Management Using Artificial Intelligence and Continuous Glucose Monitoring Sensors,” Sensors, vol. 20, no. 14, p. 3870, Jul. 2020, doi: 10.3390/s20143870.
Y. Liu et al., “Gut Microbiome Fermentation Determines the Efficacy of Exercise for Diabetes Prevention,” Cell Metab., vol. 31, no. 1, pp. 77-91.e5, Jan. 2020, doi: 10.1016/j.cmet.2019.11.001.
L. Khorraminezhad et al., “Dairy product intake modifies gut microbiota composition among hyperinsulinemic individuals,” Eur. J. Nutr., vol. 60, no. 1, pp. 159–167, Feb. 2021, doi: 10.1007/s00394-020-02226-z.
O. Ben-Yacov et al., “Gut microbiome modulates the effects of a personalised postprandial-targeting (PPT) diet on cardiometabolic markers: a diet intervention in pre-diabetes,” Gut, vol. 72, no. 8, pp. 1486–1496, Aug. 2023, doi: 10.1136/gutjnl-2022-329201.
S. Joshi et al., “Digital Twin-Enabled Personalized Nutrition Improves Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes: Results of a 1-Year Randomized Controlled Study,” Endocr. Pract., vol. 29, no. 12, pp. 960–970, Dec. 2023, doi: 10.1016/j.eprac.2023.08.016.
P. Zhang, C. Fonnesbeck, D. C. Schmidt, J. White, S. Kleinberg, and S. A. Mulvaney, “Using Momentary Assessment and Machine Learning to Identify Barriers to Self-management in Type 1 Diabetes: Observational Study,” JMIR mHealth uHealth, vol. 10, no. 3, p. e21959, Mar. 2022, doi: 10.2196/21959.
E. K. Oikonomou, M. A. Suchard, D. K. McGuire, and R. Khera, “Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes,” Diabetes Care, vol. 45, no. 4, pp. 965–974, Apr. 2022, doi: 10.2337/dc21-1765.
S. H. A. Faruqui et al., “Development of a Deep Learning Model for Dynamic Forecasting of Blood Glucose Level for Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Controlled Trial,” JMIR mHealth uHealth, vol. 7, no. 11, p. e14452, Nov. 2019, doi: 10.2196/14452.
P. Avari et al., “Safety and Feasibility of the PEPPER Adaptive Bolus Advisor and Safety System: A Randomized Control Study,” Diabetes Technol. Ther., vol. 23, no. 3, pp. 175–186, Mar. 2021, doi: 10.1089/dia.2020.0301.
Y.-B. Lee et al., “An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial,” Diabetes Care, vol. 46, no. 5, pp. 959–966, May 2023, doi: 10.2337/dc22-1929.
P. K. Roberts et al., “Quantification of Fluid Resolution and Visual Acuity Gain in Patients With Diabetic Macular Edema Using Deep Learning,” JAMA Ophthalmol., vol. 138, no. 9, p. 945, Sep. 2020, doi: 10.1001/jamaophthalmol.2020.2457.
M. Habes et al., “Patterns of Regional Brain Atrophy and Brain Aging in Middle- and Older-Aged Adults With Type 1 Diabetes,” JAMA Netw. Open, vol. 6, no. 6, p. e2316182, Jun. 2023, doi: 10.1001/jamanetworkopen.2023.16182.
K. Sarici et al., “Longitudinal Quantitative Ultrawide-field Fluorescein Angiography Dynamics in the RUBY Diabetic Macular Edema Study,” Ophthalmol. Retin., vol. 7, no. 6, pp. 543–552, Jun. 2023, doi: 10.1016/j.oret.2023.01.018.
J. R. Abraham et al., “Aqueous Cytokine Expression and Higher Order OCT Biomarkers: Assessment of the Anatomic-Biologic Bridge in the IMAGINE DME Study,” Am. J. Ophthalmol., vol. 222, pp. 328–339, Feb. 2021, doi: 10.1016/j.ajo.2020.08.047.
C. J. Popp et al., “Effect of a Personalized Diet to Reduce Postprandial Glycemic Response vs a Low-fat Diet on Weight Loss in Adults With Abnormal Glucose Metabolism and Obesity,” JAMA Netw. Open, vol. 5, no. 9, p. e2233760, Sep. 2022, doi: 10.1001/jamanetworkopen.2022.33760.
X. Zou et al., “Differential effect of interventions in patients with prediabetes stratified by a machine learning‐based diabetes progression prediction model,” Diabetes, Obes. Metab., vol. 26, no. 1, pp. 97–107, Jan. 2024, doi: 10.1111/dom.15291.
J. Li et al., “Inflammation-related downregulation of zonula Occludens-1 in fetal membrane contributes to development of prelabor rupture of membranes,” Placenta, vol. 99, pp. 173–179, Sep. 2020, doi: 10.1016/j.placenta.2020.07.029.
X. Sun et al., “Effects of Endurance Exercise and Vitamin D Supplementation on Insulin Resistance and Plasma Lipidome in Middle-Aged Adults with Type 2 Diabetes,” Nutrients, vol. 15, no. 13, p. 3027, Jul. 2023, doi: 10.3390/nu15133027.
J. Sampedro-Gómez et al., “Machine Learning to Predict Stent Restenosis Based on Daily Demographic, Clinical, and Angiographic Characteristics,” Can. J. Cardiol., vol. 36, no. 10, pp. 1624–1632, Oct. 2020, doi: 10.1016/j.cjca.2020.01.027.
C. Khanji, L. Lalonde, C. Bareil, M.-T. Lussier, S. Perreault, and M. E. Schnitzer, “Lasso Regression for the Prediction of Intermediate Outcomes Related to Cardiovascular Disease Prevention Using the TRANSIT Quality Indicators,” Med. Care, vol. 57, no. 1, pp. 63–72, Jan. 2019, doi: 10.1097/MLR.0000000000001014.
A. Gastaldelli et al., “PPAR‐γ‐induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH,” Liver Int., vol. 41, no. 11, pp. 2659–2670, Nov. 2021, doi: 10.1111/liv.15005.
A. Moyen, A. I. Rappaport, C. Fleurent-Grégoire, A.-J. Tessier, A.-S. Brazeau, and S. Chevalier, “Relative Validation of an Artificial Intelligence–Enhanced, Image-Assisted Mobile App for Dietary Assessment in Adults: Randomized Crossover Study,” J. Med. Internet Res., vol. 24, no. 11, p. e40449, Nov. 2022, doi: 10.2196/40449.
B. Seethaler et al., “Short-chain fatty acids are key mediators of the favorable effects of the Mediterranean diet on intestinal barrier integrity: data from the randomized controlled LIBRE trial,” Am. J. Clin. Nutr., vol. 116, no. 4, pp. 928–942, Oct. 2022, doi: 10.1093/ajcn/nqac175.
P. Saux et al., “Development and validation of an interpretable machine learning-based calculator for predicting 5-year weight trajectories after bariatric surgery: a multinational retrospective cohort SOPHIA study,” Lancet Digit. Heal., vol. 5, no. 10, pp. e692–e702, Oct. 2023, doi: 10.1016/S2589-7500(23)00135-8.
T. V Varga et al., “Predictive utilities of lipid traits, lipoprotein subfractions and other risk factors for incident diabetes: a machine learning approach in the Diabetes Prevention Program,” BMJ Open Diabetes Res. Care, vol. 9, no. 1, p. e001953, Mar. 2021, doi: 10.1136/bmjdrc-2020-001953.
A. Nayak et al., “Use of Voice-Based Conversational Artificial Intelligence for Basal Insulin Prescription Management Among Patients With Type 2 Diabetes,” JAMA Netw. Open, vol. 6, no. 12, p. e2340232, Dec. 2023, doi: 10.1001/jamanetworkopen.2023.40232.
R. Unsworth et al., “Safety and Efficacy of an Adaptive Bolus Calculator for Type 1 Diabetes: A Randomized Controlled Crossover Study,” Diabetes Technol. Ther., vol. 25, no. 6, pp. 414–425, Jun. 2023, doi: 10.1089/dia.2022.0504.
S.-M. Park et al., “Biportal endoscopic versus microscopic lumbar decompressive laminectomy in patients with spinal stenosis: a randomized controlled trial,” Spine J., vol. 20, no. 2, pp. 156–165, Feb. 2020, doi: 10.1016/j.spinee.2019.09.015.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Asbath, Prima Dewi Kusumawati, Pius Weraman, Eli Sabrifha, Ahmad Zil Fauzi
This work is licensed under a Creative Commons Attribution 4.0 International License.
